Product Type > Proteins

Recombinant SARS-CoV-2 Envelope Protein (RP01263LQ)

Publications (8) Datasheet

Overview

Product name Recombinant SARS-CoV-2 Envelope Protein
Catalog No. RP01263LQ
Description Recombinant SARS-CoV-2(2019-nCoV) Envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of SARS-COV-2(2019-nCoV) Envelope (Accession #QHD43418.1) fused with an initial Met, a 6×His, Avi tag at the N-terminus.
Bio-Activity Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Envelope at 2 μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid with a linear range of 1.2-41.1 ng/mL.
Purity > 95% by SDS-PAGE.
Endotoxin < 0.1 EU/μg of the protein by LAL method.
Formulation Supplied as a 0.22 μm filtered solution in 20mM Tris, 250mM NaCl, 0.5%TritonX-100, pH 8.0.Contact us for customized product form or formulation.
Species SARS-CoV-2
Calculated MW 11.4kDa
Synonym 2019-nCoV E protein; 2019-nCoV sM protein; Envelope protein; Env polyprotein; Envelope glycoprotein; env; COVID-19; E
Expressed Host E. coli
Tag N-His&Avi
Gene ID 43740570
Storage This product is stable at ≤ -70°C for up to 6 months from the date of receipt.
For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature.

Inquire About This Product

Submit your question about RP01263LQ below and we will get back to you within one business day.

Alternatively, call us at 888.754.5670.

Publishing research using RP01263LQ? Please let us know so that we can cite the reference in this datasheet.

* For research use only. Not for therapeutic or diagnostic purposes.

Select size and quantity
Request a free sample
Contact us to order